These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 21674736)
1. A single direct injection into the left ventricular wall of an adeno-associated virus 9 (AAV9) vector expressing extracellular superoxide dismutase from the cardiac troponin-T promoter protects mice against myocardial infarction. Prasad KM; Smith RS; Xu Y; French BA J Gene Med; 2011 Jun; 13(6):333-41. PubMed ID: 21674736 [TBL] [Abstract][Full Text] [Related]
2. Cardiac-selective expression of extracellular superoxide dismutase after systemic injection of adeno-associated virus 9 protects the heart against post-myocardial infarction left ventricular remodeling. Konkalmatt PR; Beyers RJ; O'Connor DM; Xu Y; Seaman ME; French BA Circ Cardiovasc Imaging; 2013 May; 6(3):478-86. PubMed ID: 23536266 [TBL] [Abstract][Full Text] [Related]
3. Adeno-associated virus serotype 9 administered systemically after reperfusion preferentially targets cardiomyocytes in the infarct border zone with pharmacodynamics suitable for the attenuation of left ventricular remodeling. Konkalmatt PR; Wang F; Piras BA; Xu Y; O'Connor DM; Beyers RJ; Epstein FH; Annex BH; Hossack JA; French BA J Gene Med; 2012; 14(9-10):609-20. PubMed ID: 23065925 [TBL] [Abstract][Full Text] [Related]
4. Effect of heart ischemia and administration route on biodistribution and transduction efficiency of AAV9 vectors. García-Olloqui P; Rodriguez-Madoz JR; Di Scala M; Abizanda G; Vales Á; Olagüe C; Iglesias-García O; Larequi E; Aguado-Alvaro LP; Ruiz-Villalba A; Prosper F; Gonzalez-Aseguinolaza G; Pelacho B J Tissue Eng Regen Med; 2020 Jan; 14(1):123-134. PubMed ID: 31677236 [TBL] [Abstract][Full Text] [Related]
5. Atrial-Specific Gene Delivery Using an Adeno-Associated Viral Vector. Ni L; Scott L; Campbell HM; Pan X; Alsina KM; Reynolds J; Philippen LE; Hulsurkar M; Lagor WR; Li N; Wehrens XHT Circ Res; 2019 Jan; 124(2):256-262. PubMed ID: 30582449 [TBL] [Abstract][Full Text] [Related]
6. AAV-9 mediated phosphatase-1 inhibitor-1 overexpression improves cardiac contractility in unchallenged mice but is deleterious in pressure-overload. Schwab DM; Tilemann L; Bauer R; Heckmann M; Jungmann A; Wagner M; Burgis J; Vettel C; Katus HA; El-Armouche A; Müller OJ Gene Ther; 2018 Jan; 25(1):13-19. PubMed ID: 29350681 [TBL] [Abstract][Full Text] [Related]
9. Robust cardiomyocyte-specific gene expression following systemic injection of AAV: in vivo gene delivery follows a Poisson distribution. Prasad KM; Xu Y; Yang Z; Acton ST; French BA Gene Ther; 2011 Jan; 18(1):43-52. PubMed ID: 20703310 [TBL] [Abstract][Full Text] [Related]
10. Intravenous delivery of adeno-associated viral vector serotype 9 mediates effective gene expression in ischemic stroke lesion and brain angiogenic foci. Shen F; Kuo R; Milon-Camus M; Han Z; Jiang L; Young WL; Su H Stroke; 2013 Jan; 44(1):252-4. PubMed ID: 23250995 [TBL] [Abstract][Full Text] [Related]
11. Sustained viral gene delivery from a micro-fibrous, elastomeric cardiac patch to the ischemic rat heart. Gu X; Matsumura Y; Tang Y; Roy S; Hoff R; Wang B; Wagner WR Biomaterials; 2017 Jul; 133():132-143. PubMed ID: 28433936 [TBL] [Abstract][Full Text] [Related]
15. Gene transfer as a strategy to achieve permanent cardioprotection II: rAAV-mediated gene therapy with heme oxygenase-1 limits infarct size 1 year later without adverse functional consequences. Li Q; Guo Y; Ou Q; Wu WJ; Chen N; Zhu X; Tan W; Yuan F; Dawn B; Luo L; Hunt GN; Bolli R Basic Res Cardiol; 2011 Nov; 106(6):1367-77. PubMed ID: 21785893 [TBL] [Abstract][Full Text] [Related]
16. Neuraminidase-mediated desialylation augments AAV9-mediated gene expression in skeletal muscle. Zhu H; Wang T; John Lye R; French BA; Annex BH J Gene Med; 2018 Sep; 20(9):e3049. PubMed ID: 30101537 [TBL] [Abstract][Full Text] [Related]
17. Spacial and Temporal Patterns of Gene Expression After Cardiac MEK1 Gene Transfer Improve Post-Infarction Remodeling Without Inducing Global Hypertrophy. Fan Y; Yang YL; Yeh CC; Mann MJ J Cell Biochem; 2017 Apr; 118(4):775-784. PubMed ID: 27639174 [TBL] [Abstract][Full Text] [Related]
18. Transduction of the central nervous system after intracerebroventricular injection of adeno-associated viral vectors in neonatal and juvenile mice. Gholizadeh S; Tharmalingam S; Macaldaz ME; Hampson DR Hum Gene Ther Methods; 2013 Aug; 24(4):205-13. PubMed ID: 23808551 [TBL] [Abstract][Full Text] [Related]
19. Comparison of adeno-associated virus serotypes and delivery methods for cardiac gene transfer. Fang H; Lai NC; Gao MH; Miyanohara A; Roth DM; Tang T; Hammond HK Hum Gene Ther Methods; 2012 Aug; 23(4):234-41. PubMed ID: 22966786 [TBL] [Abstract][Full Text] [Related]
20. AAV9-mediated CIRP gene transfer protects against cardiac dysfunction and remodelling in a rat model of myocardial infarction. Zhong P; Yang S; Fang C; Li Y; Song S; Chen M; Chen J J Cell Mol Med; 2024 Oct; 28(19):e70084. PubMed ID: 39400399 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]